COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,641 Articles (22,913 medRxiv, 8,728 bioRxiv)

Most recent first Previous |  Page 1764: Articles 17631-17640  | Next

May we overcome the current serious limitations for distributing reconstituted mRNA vaccines?
Grau, S., Ferrandez, O., Martin-Garcia, E., Maldonado, R.
10.1101/2021.03.09.21253129 — Posted: 2021-03-12
Universal Rule for Covid 19 and Herd Immunity in the US
Kuriyan, J.
10.1101/2021.03.05.21251577 — Posted: 2021-03-12
SARS-CoV-2 antibody prevalence and determinants of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020
Coyer, L., Boyd, A., Schinkel, J., Agyemang, C., Galenkamp, H., Koopman, A. D. M., Leenstra, T., Moll van Charante, E. P., van den Born, B.-J. H., Lok, A., Verhoeff, A., Zwinderman, A. H., Jurriaans, S., van Vught, L. A., Stronks, K., Prins, M.
10.1101/2021.03.08.21252788 — Posted: 2021-03-12
Evolutionary and phenotypic characterization of spike mutations in a new SARS-CoV-2 Lineage reveals two Variants of Interest
Ruiz-Rodriguez, P., Frances-Gomez, C., Chiner-Oms, A., López, M. G., Jiménez-Serrano, S., Cancino-Muñoz, I., Ruiz-Hueso, P., Torres-Puente, M., Bracho, M. A., D'Auria, G., Martinez-Priego, L., Guerreiro, M., Montero-Alonso, M., Gomez, M. D., Piñana, J. L., SeqCOVID-SPAIN consortium, , González-Candelas, F., Comas, I., Marina, A., Geller, R., Coscolla, M.
10.1101/2021.03.08.21253075 — Posted: 2021-03-12
COVID-19 lockdowns may reduce resistance genes diversity in the human microbiome and the need for antibiotics
Rebelo, J. S., Domingues, C. P., Dionisio, F., Gomes, M. C., Botelho, A., Nogueira, T.
10.1101/2021.03.08.21253164 — Posted: 2021-03-12
Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada
Matic, N., Lowe, C. F., Ritchie, G., Stefanovic, A., Lawson, T., Jang, W., Young, M., Dong, W., Brumme, Z. L., Brumme, C. J., Leung, V., Romney, M. G.
10.1101/2021.03.04.21252928 — Posted: 2021-03-12
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Woodford, J., Sagara, I., Kwan, J., Zeguime, A., Zaidi, I., Attaher, O., Kone, M., Doritchamou, J. Y. A., Renn, J., Maiga, M., Diawara, H., Snow-Smith, M., Alani, N., Doucoure, M., Kosik, I., Holly, J., Yewdell, J., Esposito, D., Sadtler, K., Dicko, A., Duffy, P. E.
10.1101/2021.03.08.21252784 — Posted: 2021-03-12
Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of West Bengal: A Retrospective study
Roy, S., Samajdar, S. S., Tripathi, S. K., Mukherjee, S., Bhattacharjee, K.
10.1101/2021.03.08.21252883 — Posted: 2021-03-12
Forecasting the COVID-19 epidemic integrating symptom search behavior: an infodemiology study
Rabiolo, A., Alladio, E., Morales, E., McNaught, A. I., Bandello, F., Afifi, A. A., Marchese, A.
10.1101/2021.03.09.21253186 — Posted: 2021-03-12
Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: insights and limitations from uneven sequencing efforts
Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., Thompson, C. E.
10.1101/2021.03.08.21253152 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).